Published 2006 | Version v1
Journal article

Preparation and biodistribution of 153Sm-EDTMP complex for palliation of pain from osseous metastases

  • 1. Labelled Compounds Department, and Radioactive Isotopes and Generators Department and Hot Labs. Centre, Atomic Energy Authority, Cairo (Egypt)

Description

The radiotherapeutical 153Sm-ethylene diamine tetra methylene phosphonic acid (153Sm-EDTMP) is considered a radio-pharmaceutical compound of choice in the treatment of pain dissemination of bone metastatic tumor. 153Sm was obtained by neutron irradiation of natural Sm2O3 targets with a specific activity 740 - 1850 MBq/mg. Labelling process of EDTMP with Sm-153 was carried out at ph 7.5 - 8 and heating at 70 degree C for 30min. The radiochemical purity was ascertained by paper chromatography and in-vitro stability was studied. The product was found stable for over 24h with high radiochemical yield more than 97%. The biodistribution results in male Albino Swiss mice showed good bone uptake and prolonged retention, with adequately rapid clearance from blood and no retention in any non-target

Additional details

Publishing Information

Journal Title
Isotope and Radiation Research
Journal Volume
38
Journal Issue
2
Journal Page Range
p. 347-354
ISSN
0021-1907